Allianz Asset Management Gmb H Rigel Pharmaceuticals Inc Transaction History

Allianz Asset Management Gmb H

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$1.41 - $2.05 $29,552 - $42,965	-20,959 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$1.27 - $3.0 $7,369 - $17,409	-5,803 Reduced 21.68%	20,959 $33,000
Q4 2019 Feb 13, 2020	BUY	$1.6 - $2.43 $42,819 - $65,031	26,762 New	26,762 $57,000
Q2 2019 Aug 08, 2019	SELL	$2.02 - $2.61 $968,131 - $1.25 Million	-479,273 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$2.0 - $2.65 $5,008 - $6,635	-2,504 Reduced 0.52%	479,273 $1.23 Million
Q4 2018 Feb 14, 2019	SELL	$2.08 - $3.36 $35,726 - $57,711	-17,176 Reduced 3.44%	481,777 $1.11 Million
Q3 2018 Nov 13, 2018	BUY	$2.6 - $3.59 $111,615 - $154,115	42,929 Added 9.41%	498,953 $1.6 Million
Q2 2018 Aug 13, 2018	SELL	$2.83 - $4.11 $7,281 - $10,575	-2,573 Reduced 0.56%	456,024 $1.29 Million
Q1 2018 May 14, 2018	BUY	$3.54 - $4.54 $1.62 Million - $2.08 Million	458,597 New	458,597 $1.62 Million

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $4.5B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.